[1]
Barkin, J.A., Keihanian, T., Barkin, J.S., Antequera, C.M. y Moshiree, B. 2019. Preferential usage of rifaximin for the treatment of hydrogen-positive small intestinal bacterial overgrowth. Revista de Gastroenterología del Perú. 39, 2 (jul. 2019), 111–5. DOI:https://doi.org/10.47892/rgp.2019.392.955.